Ir.retrophin.com

The following excerpt is from the company's SEC filing. - Three Phase 3 Epidiolex clinical trials fully recruited above target sample size – on track for initial data in Q1 2016 - - Significant clinical activity in multiple cannabinoid pipeline programs...

By Jason Napodano, CFA We recently sat down with Amarantus Bioscience Holdings (AMBS) CEO, Gerald Commissiong. The meeting confirmed our belief that Amarantus is in the midst of a fundamental turnaround and has significant growth potential over the...

BPI publisher, Brian Caine Since 2003, the mission of BioProcess International has been to connect biopharmaceutical scientists and decision makers to the science, technology, and expertise that can positively influence and improve existing bioprocesses...

Menlo Park, CA, and Brussels, Belgium — Dermira, Inc., a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients (Nasdaq:DERM), and UCB, a global biopharmaceutical...

HONG KONG, CHINA—(Marketwired – Aug 2, 2016) – Hutchison China Meditech Limited ( NASDAQ : HCM ) Nasdaq: HCM Hutchison China MediTech Limited (“Chi–Med”) Reports Interim Results for the Six Months Ended June 30, 2016, Provides 2016 Financial Guidance...